Shengbao Bio
Shenzhen
About Shengbao Bio
Shengbao Bio is committed to the development of novel live bacterial medications, leveraging gene circuits and precise regulation of gene and payload expression.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2024)
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/shengbao-bio-2452895 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.